web analytics
New GMP Manufacturing Facility to manufacture clinical trial supplies | Velesco Pharma

Velesco Opens GMP Manufacture Facility


velesco logo pms coa 405131 lc2 copy



Gerry Cox

Chief Operating Officer

Velesco Pharmaceutical Services






(Plymouth, MI; June 9, 2009) – Velesco Pharmaceutical Services, a company providing analytical method development, drug formulation, stability testing and consulting services to biotech and pharmaceutical companies, opened a manufacturing facility and office in Kalamazoo, MI and has moved its Ann Arbor, MI laboratories to the Michigan Life Science and Innovation Center (MLSIC) in Plymouth, MI.       


Velesco’s new 10,000 square foot office and manufacturing facility at the Kalamazoo Commerce Center will manufacture non-sterile cGMP clinical trial supplies for pharmaceutical companies developing new medicines.  This facility will focus on providing clinical supplies for early phase trials.  Product offerings include powder-in-capsule, powder-in-bottle, ointments/creams, oral and topical liquids, over-encapsulation for blinded studies and packaging.


The company move provides expanded space to accommodate the growth of its analytical and drug formulation laboratory services.


“Velesco’s addition of clinical trial material manufacturing capabilities allows us to provide a full service offering to our clients as they move from pre-clinical drug development into the clinic,” said CEO and co-founder David Barnes, Ph.D. 


“The life science talent in Michigan compelled us to stay and grow here,” said Velesco Chief Operating Officer and co-founder Gerry Cox.  “There’s a uniquely high concentration of the experienced pharmaceutical researchers Velesco needs to be successful in its aggressive growth plans.” 


In conjunction with this expansion, Velesco was awarded a state High Tech Mega tax credit by the Michigan Economic Growth Authority.  This credit will enhance Velesco’s operational capabilities.


About Velesco Pharmaceutical Services

Velesco Pharmaceutical Services was formed in 2007 by former Pfizer Michigan R&D colleagues and focuses on supporting the early stage work of pharmaceutical companies. Velesco’s founders, analytical chemists and drug formulation experts are pharmaceutical industry veterans with a track record of moving compounds through this significant phase of the drug development process. Velesco works with state of the art equipment in a high-quality (former Pfizer) facility. Velesco delivers on time high quality products and services, assistance with the FDA registration process and insightful consultation.  More information about Velesco can be found at www.velescopharma.com.


News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100